Skip to main content
TipRanks
Go Ultimate75% OFF

Avalo Therapeutics (C6K0) Q3 2022 Earnings Report

0 Followers

DE:C6K0 Q3 2022 EPS Results

Actual EPS
EUR 74.02
Consensus EPS
-EUR 191.05
Beat/Miss
Beat by +EUR 265.07
One Year Ago EPS
-EUR 444.14

DE:C6K0 Q3 2022 Revenue Results

Actual Revenue
EUR 13.56M
Expected Revenue
EUR 1.14M
Beat/Miss
Beat by +EUR 12.42M
YoY Revenue Growth
+1007.33%

Earnings Announcement Details

Quarter
Q3 2022
Date
11/07/2022
Time
Before Open
Conference Call
Monday, November 7, 2022
DE:C6K0 Upcoming Earnings

Avalo Therapeutics's next earnings date is estimated for March 31, 2027, based on past reporting schedules.

Q3 2022 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q3 2022 Earnings Slide Deck

No slide deck is available for this earnings event.

Q3 2022 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:C6K0 Earnings History

DE:C6K0 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 31, 20272026 (Q4)-0.41--0.68――
Nov 05, 20262026 (Q3)-0.53-0.31-1.9984.47% (+1.68)
Aug 06, 20262026 (Q2)-0.53-0.75-1.7456.77% (+0.99)
May 13, 20262026 (Q1)-0.93-0.89-1.1321.60% (+0.24)
Mar 23, 20262025 (Q4)-1.32-0.68-2.0967.39% (+1.41)
Nov 06, 20252025 (Q3)-1.50-1.99-2.5722.61% (+0.58)
Aug 07, 20252025 (Q2)-1.27-1.74-12.7686.35% (+11.02)
May 12, 20252025 (Q1)-1.21-1.13-127.9199.11% (+126.77)
Mar 20, 20252024 (Q4)-0.15-2.09-9.1677.23% (+7.08)
Nov 07, 20242024 (Q3)-1.08-2.57-23.9589.28% (+21.38)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed